Business Description
BioHarvest Sciences Inc
ISIN : CA09076J2074
Total Employee Number:
89Description
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.03 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.79 | |||||
Debt-to-EBITDA | -2.18 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -2.04 | |||||
Beneish M-Score | -2.13 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 64.5 | |||||
3-Year EBITDA Growth Rate | 19.5 | |||||
3-Year EPS without NRI Growth Rate | 12.1 | |||||
3-Year FCF Growth Rate | 13.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 27.56 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.24 | |||||
Quick Ratio | 1.75 | |||||
Cash Ratio | 1.39 | |||||
Days Inventory | 119.65 | |||||
Days Sales Outstanding | 20.55 | |||||
Days Payable | 75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.9 | |||||
Shareholder Yield % | 0.89 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.95 | |||||
Operating Margin % | -17.99 | |||||
Net Margin % | -31.21 | |||||
EBITDA Margin % | -20.28 | |||||
FCF Margin % | -30.31 | |||||
OCF Margin % | -24 | |||||
ROE % | -77.17 | |||||
ROA % | -27.58 | |||||
ROIC % | -27.58 | |||||
3-Year ROIIC % | 80.66 | |||||
ROC (Joel Greenblatt) % | -50.46 | |||||
ROCE % | -31.55 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.08 | |||||
PB Ratio | 2.12 | |||||
Price-to-Tangible-Book | 2.13 | |||||
EV-to-EBIT | -4.64 | |||||
EV-to-Forward-EBIT | -7.34 | |||||
EV-to-EBITDA | -5.76 | |||||
EV-to-Forward-EBITDA | -11.25 | |||||
EV-to-Revenue | 1.17 | |||||
EV-to-Forward-Revenue | 0.83 | |||||
EV-to-FCF | -3.85 | |||||
Price-to-GF-Value | 0.26 | |||||
| Price-to-Net-Current-Asset-Value | 31.04 | |||||
Earnings Yield (Greenblatt) % | -21.55 | |||||
FCF Yield % | -25.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioHarvest Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 107.543 | ||
| EPS (TTM) (₪) | -1.545 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (₪) | - | ||
| 20-Day SMA (₪) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₪) | 5.898 - 6 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioHarvest Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioHarvest Sciences Inc Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 61 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 60 days | ||
| Q3 Investor Summit Virtual (Bioharvest) | 2026-08-26 09:00 | -- | ||
| Canaccord Genuity 46th Annual Growth Conference | 2026-08-12 13:00 | -- | ||
| Second quarter earnings conference call for 2026 | 2026-08-11 08:00 | -- | ||
| Second quarter earnings results for 2026 | 2026-08-11 | -- | ||
| Maxim Health, Wellness & Longevity Conference | 2026-07-22 10:00 | -- | ||
| General meeting for 2026 | 2026-06-25 10:00 | -- | ||
| Guidance call for 2026 | 2026-06-24 16:30 | -- | ||
| First quarter earnings conference call for 2026 | 2026-05-14 08:00 | -- |
Show
Entries
BioHarvest Sciences Inc Frequently Asked Questions
What is BioHarvest Sciences Inc(XTAE:BHST)'s stock price today?
The current price of XTAE:BHST is ₪5.90. The 52 week high of XTAE:BHST is ₪6.00 and 52 week low is ₪5.90.
When is next earnings date of BioHarvest Sciences Inc(XTAE:BHST)?
The next earnings date of BioHarvest Sciences Inc(XTAE:BHST) is 2026-11-13 Est..
Does BioHarvest Sciences Inc(XTAE:BHST) pay dividends? If so, how much?
BioHarvest Sciences Inc(XTAE:BHST) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers